No worries Koo. Resverlogix has no divulged too much about their renal trial plans yet....just scattered bits and pieces. I have just pieced together those bits and pieces from 2016 communications and presentations. As we all know, plans can change. Since part of today's R&D presentation is from the chairman of Resverlogix's Renal Clinical Advisory Board, Dr. Kamyar Kalantar-Zadeh, I am optimistic that we will have a better understanding of the renal plans after today.

BearDownAZ